Patient Derived Preclinical Models
Launched by MAYO CLINIC · Apr 5, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on collecting tumor samples from patients with cancer to better understand the disease and improve treatment options in the future. By gathering tissue from tumors, as well as normal tissues when available, and blood samples, researchers hope to develop new ways to treat cancer more effectively. This study is a collaborative effort aimed at advancing cancer research.
To be considered for this trial, participants need to be at least 18 years old and must be in good health enough to undergo a standard biopsy or surgery to collect the tissue. However, patients with certain medical conditions or those who cannot safely provide informed consent may not be eligible. If you join this study, you can expect to have a biopsy that is assessed to ensure it's safe for you, and your participation will contribute to important cancer research that could help improve future outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age and older
- • Patient is a good medical candidate for a standard of care or research biopsy or surgical procedure to obtain tissue
- Exclusion Criteria:
- • Uncontrolled concurrent illness including psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly give written informed consent
- • Institutionalized or incarcerated patients
- • Inaccessible tumor for biopsy or patient does not have tumor tissue available for research use
- • Biopsy must not be considered more than minimal risk to the patient.
- * Have a contraindication to percutaneous biopsy including:
- • 1. Significant coagulopathy that cannot be adequately corrected.
- • 2. Severely compromised cardiopulmonary function or hemodynamic instability.
- • 3. Lack of a safe pathway to the lesion per the interventional radiologist.
- • 4. Inability of the patient to cooperate with, or to be positioned for, the procedure.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Rochester, Minnesota, United States
Patients applied
Trial Officials
Aaron S. Mansfield, M.D.
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials